US Continuous Glucose Monitoring Market: Competitive Landscape and Growth Trends 2025-2033

Key Insights

The US Continuous Glucose Monitoring (CGM) market is experiencing robust growth, driven by increasing prevalence of diabetes, technological advancements leading to smaller, more accurate, and user-friendly devices, and rising demand for improved diabetes management. The market, valued at approximately $3.5 billion in 2025 (estimated based on provided CAGR and market size), is projected to exhibit a Compound Annual Growth Rate (CAGR) of 9.60% from 2025 to 2033. This expansion is fueled by several key factors. The aging population, coupled with increasing rates of obesity and sedentary lifestyles, contributes significantly to the rising number of diabetes cases, creating a substantial demand for effective monitoring solutions. Furthermore, the integration of CGM systems with insulin pumps and mobile applications offers patients greater control over their condition and improves their quality of life, stimulating market adoption. The increasing reimbursement coverage for CGM devices by private and public insurers also significantly impacts market growth. Competitive innovation, with companies like Dexcom, Medtronic, and Abbott Diabetes Care leading the way, contributes to continuous improvement in device performance and features, further driving market expansion.

Despite the favorable market dynamics, certain challenges remain. High initial costs of CGM devices, coupled with the ongoing need for replacement sensors, can pose barriers to entry for some patients. While technological advancements address issues of accuracy and usability, ensuring consistent performance and minimizing sensor errors remains a crucial factor in maintaining market confidence. Furthermore, potential side effects related to sensor insertion and maintenance also need ongoing attention from device manufacturers and healthcare professionals. Despite these restraints, the long-term outlook for the US CGM market remains overwhelmingly positive, reflecting the growing need for effective diabetes management strategies and the continuous innovation within the sector. The market segmentation, primarily focused on sensors and durable components, will continue to evolve, with a focus on integration with broader health management ecosystems. Regional variations in market penetration within the United States will likely persist, influenced by factors such as healthcare infrastructure, insurance coverage, and awareness levels.

This in-depth report provides a comprehensive analysis of the US Continuous Glucose Monitoring (CGM) market, encompassing market dynamics, growth trends, key players, and future outlook. It serves as an invaluable resource for industry professionals, investors, and stakeholders seeking to understand this rapidly evolving sector. The report covers the parent market of Diabetes Management and the child market of Continuous Glucose Monitoring, offering a granular view of market segmentation by component (Sensors, Durables) and key players. The study period spans from 2019 to 2033, with a focus on the forecast period of 2025-2033.

US Continuous Glucose Monitoring Market Market Dynamics & Structure

The US CGM market is characterized by a dynamic interplay of factors influencing its structure and growth trajectory. Market concentration is relatively high, with key players such as Dexcom Inc., Abbott Diabetes Care, and Medtronic PLC holding significant market share. However, the emergence of innovative technologies and new entrants is gradually increasing competition. Technological innovation, driven by advancements in sensor technology, miniaturization, and data analytics, is a key growth driver. Stringent regulatory frameworks, primarily set by the FDA, influence product approvals and market access. Competitive product substitutes, including traditional blood glucose monitoring methods, pose a challenge to CGM adoption. The end-user demographic comprises individuals with type 1 and type 2 diabetes across various age groups. M&A activity within the sector remains moderate but is expected to increase with the consolidation of the market.

• Market Concentration: High, with top 3 players holding approximately xx% of market share in 2024.
• Technological Innovation: Miniaturization, improved accuracy, and integration with smart devices are key drivers.
• Regulatory Framework: FDA approval process significantly impacts market entry and product lifecycle.
• Competitive Substitutes: Traditional blood glucose meters still hold market share, creating competitive pressure.
• End-User Demographics: Primarily individuals with type 1 and type 2 diabetes, across diverse age groups.
• M&A Activity: Moderate activity observed in the historical period (2019-2024), with xx deals recorded.

US Continuous Glucose Monitoring Market Growth Trends & Insights

The US CGM market experienced robust growth during the historical period (2019-2024), driven by increasing diabetes prevalence, rising healthcare expenditure, and technological advancements. The market size, estimated at $xx million in 2024, is projected to reach $xx million by 2033, exhibiting a CAGR of xx% during the forecast period (2025-2033). Adoption rates are increasing steadily, fueled by improved accuracy, user-friendliness, and the growing awareness of the benefits of continuous glucose monitoring among patients and healthcare professionals. Technological disruptions, such as the introduction of integrated CGM systems with insulin delivery, are transforming the landscape. Shifting consumer behavior, with a preference for convenient and non-invasive monitoring methods, also contributes to market expansion.

• Market Size (2024): $xx million
• Market Size (2033, Projected): $xx million
• CAGR (2025-2033): xx%
• Market Penetration (2024): xx% among diagnosed diabetics.

Dominant Regions, Countries, or Segments in US Continuous Glucose Monitoring Market

The US CGM market demonstrates growth across all regions, but certain segments contribute more significantly. The Sensors component holds a larger market share compared to Durables due to higher replacement frequency. Growth within this segment is driven by the continuous need for sensor replacements. The demand for sensors is further fueled by technological advancements leading to improved sensor performance and user experience. Key drivers include the increasing number of diabetes diagnoses, rising patient awareness about CGM benefits, and the launch of newer generation products with advanced features. The significant growth of the sensor segment is expected to continue throughout the forecast period.

• Dominant Component: Sensors
• Key Drivers: Increasing diabetes prevalence, technological advancements, improved accuracy and convenience of sensors.
• Growth Potential: High, driven by continuous replacement needs and new product introductions.

US Continuous Glucose Monitoring Market Product Landscape

The US CGM market showcases a diverse range of products, from single-use sensors to integrated systems that include data analysis and remote monitoring capabilities. Recent product innovations focus on improved accuracy, smaller sensor sizes, and enhanced ease of use. Key features include real-time glucose data transmission, customizable alerts, and integration with mobile applications for data management and sharing. Technological advancements are enabling the development of non-invasive CGM technologies, potentially revolutionizing the market. Companies are emphasizing unique selling propositions such as longer sensor lifespan, improved accuracy and integration capabilities to stand out in the increasingly competitive market.

Key Drivers, Barriers & Challenges in US Continuous Glucose Monitoring Market

Key Drivers:

• Increasing prevalence of diabetes in the US.
• Growing awareness and acceptance of CGM technology among patients and healthcare professionals.
• Technological advancements leading to improved accuracy, smaller sensor sizes, and enhanced usability.
• Favorable reimbursement policies and insurance coverage.

Key Challenges and Restraints:

• High cost of CGM systems, posing a barrier to adoption for some patients.
• Potential for sensor inaccuracies and related complications.
• Regulatory hurdles and stringent approval processes for new products.
• Intense competition among established players and emerging companies.

Emerging Opportunities in US Continuous Glucose Monitoring Market

• Development of non-invasive CGM technologies.
• Integration with insulin pumps and other diabetes management devices to form closed-loop systems.
• Expansion into underserved populations and rural areas.
• Development of advanced analytics and artificial intelligence-driven solutions for personalized diabetes management.

Growth Accelerators in the US Continuous Glucose Monitoring Market Industry

Technological breakthroughs in sensor technology, miniaturization, and data analytics are key growth catalysts. Strategic partnerships between CGM manufacturers and pharmaceutical companies to develop integrated solutions will accelerate market growth. Expansion into untapped market segments, such as pediatric and geriatric populations, offers significant opportunities. Furthermore, increased investment in research and development for continuous glucose monitoring solutions will drive innovation and market expansion.

Key Players Shaping the US Continuous Glucose Monitoring Market Market

• Abbott Diabetes Care
• Dexcom Inc
• Medtronic PLC
• Ascensia Diabetes Care
• Eversense
• GlySens
• Other

Notable Milestones in US Continuous Glucose Monitoring Market Sector

• December 2022: Dexcom announced the FDA approval for their next-generation product, the Dexcom G7 CGM. The G7 is approved for people with all types of diabetes ages two years and older.
• October 2022: Abbott announced that the Freestyle Libre 3 is now available in pharmacies nationwide after it received FDA clearance in May 2022.

In-Depth US Continuous Glucose Monitoring Market Market Outlook

The US CGM market is poised for continued strong growth, driven by technological innovation, increased diabetes prevalence, and rising demand for convenient and effective diabetes management solutions. Strategic opportunities lie in developing integrated CGM systems, expanding into underserved markets, and focusing on data analytics to personalize diabetes care. The market's future hinges on advancements in non-invasive technologies and the ongoing collaboration between manufacturers, healthcare providers, and patients.

US Continuous Glucose Monitoring Market Segmentation

• 1. Component
  • 1.1. Sensors
  • 1.2. Durables

US Continuous Glucose Monitoring Market Segmentation By Geography

• 1. North America
  • 1.1. United States
  • 1.2. Canada
  • 1.3. Mexico
• 2. South America
  • 2.1. Brazil
  • 2.2. Argentina
  • 2.3. Rest of South America
• 3. Europe
  • 3.1. United Kingdom
  • 3.2. Germany
  • 3.3. France
  • 3.4. Italy
  • 3.5. Spain
  • 3.6. Russia
  • 3.7. Benelux
  • 3.8. Nordics
  • 3.9. Rest of Europe
• 4. Middle East & Africa
  • 4.1. Turkey
  • 4.2. Israel
  • 4.3. GCC
  • 4.4. North Africa
  • 4.5. South Africa
  • 4.6. Rest of Middle East & Africa
• 5. Asia Pacific
  • 5.1. China
  • 5.2. India
  • 5.3. Japan
  • 5.4. South Korea
  • 5.5. ASEAN
  • 5.6. Oceania
  • 5.7. Rest of Asia Pacific